0.69
0.62%
-0.0043
Handel nachbörslich:
.69
Finanzdaten der Hepion Pharmaceuticals Inc-Aktie (HEPA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
50.21%
5.1823
|
10.41 | 10.66 | 14.17 | 13.21 |
Interest Income/Expense |
80.38%
0.00435
|
0.00241 | 0.00238 | 0.00235 | 0.00232 |
Operating Income/Loss |
50.21%
-5.1823
|
-10.41 | -10.66 | -14.17 | -13.21 |
Income/Loss From Continuing Operations Before Tax |
49.23%
-5.8231
|
-11.47 | -10.53 | -14.08 | -13.26 |
Income Tax Expense/Benefit |
625.94%
-2.9693
|
-0.409 | - | - | - |
Income/Loss From Continuing Operations After Tax |
74.20%
-2.8538
|
-11.06 | -10.53 | -14.08 | -13.26 |
Net Income/Loss
|
74.20%
-2.8538
|
-11.06 | -10.53 | -14.08 | -13.26 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,391%
5.0725
|
0.1453 | 3.8383 | 3.8265 | 3.8115 |
Diluted Average Shares |
3,391%
5.0725
|
0.1453 | 3.8383 | 3.8265 | 3.8115 |
Basic Earnings Per Share |
76.86%
-0.56
|
-2.42 | -2.74 | -3.68 | -3.48 |
Diluted Earnings Per Share |
76.86%
-0.56
|
-2.42 | -2.74 | -3.68 | -3.48 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):